- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 216.96M sh |
| Shares Diluted | Q1 2026 · Mar 28, 2026 | 222.42M sh |
| Shares Diluted | Q1 2026 · Mar 29, 2025 | 221.85M sh |
| Stock Repurchased | Q1 2026 · Mar 28, 2026 | $5.85M |
| Stock Repurchased restated | Q1 2026 · Mar 29, 2025 | $0 |
| Capex | Q1 2026 · Mar 28, 2026 | $7.13M |
| Capex | Q1 2026 · Mar 29, 2025 | $5.52M |
| Operating Cash Flow | Q1 2026 · Mar 28, 2026 | −$150.64M |
| Operating Cash Flow | Q1 2026 · Mar 29, 2025 | −$5.85M |
| Short Term Investments | Q1 2026 · Mar 28, 2026 | $94.94M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $69.46M |
| Cash And Equivalents | Q1 2026 · Mar 28, 2026 | $135.79M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $329.65M |
| Stockholders Equity | Q1 2026 · Mar 28, 2026 | $1.61B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.59B |
| Stockholders Equity | Q1 2026 · Mar 29, 2025 | $1.44B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.42B |
| Current Liabilities | Q1 2026 · Mar 28, 2026 | $290.79M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $323.24M |
| Total Liabilities | Q1 2026 · Mar 28, 2026 | $1.52B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.56B |
| Current Assets | Q1 2026 · Mar 28, 2026 | $948.27M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $951.25M |
| Total Assets | Q1 2026 · Mar 28, 2026 | $3.14B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.15B |
| Eps Diluted | Q1 2026 · Mar 28, 2026 | $0.11 |
| Eps Diluted | Q1 2026 · Mar 29, 2025 | $0.06 |
| Eps Basic | Q1 2026 · Mar 28, 2026 | $0.11 |
| Eps Basic | Q1 2026 · Mar 29, 2025 | $0.07 |
| Sga Expense | Q1 2026 · Mar 28, 2026 | $62.59M |
| Sga Expense restated | Q1 2026 · Mar 29, 2025 | $57M |
| Rd Expense | Q1 2026 · Mar 28, 2026 | $6.76M |
| Rd Expense | Q1 2026 · Mar 29, 2025 | $5.99M |
| Net Income | Q1 2026 · Mar 28, 2026 | $23.36M |
| Net Income | Q1 2026 · Mar 29, 2025 | $14.33M |
| Operating Income | Q1 2026 · Mar 28, 2026 | $42.49M |
| Operating Income | Q1 2026 · Mar 29, 2025 | $33.51M |
| Gross Profit | Q1 2026 · Mar 28, 2026 | $118.7M |
| Gross Profit restated | Q1 2026 · Mar 29, 2025 | $105.25M |
| Cost Of Revenue | Q1 2026 · Mar 28, 2026 | $136.52M |
| Cost Of Revenue restated | Q1 2026 · Mar 29, 2025 | $123.59M |
| Revenue | Q1 2026 · Mar 28, 2026 | $255.22M |
| Revenue | Q1 2026 · Mar 29, 2025 | $228.84M |